LEXINGTON, Mass., April 22, 2024 (GLOBE NEWSWIRE) Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that it will present a broad set
Some of the top growth drivers for Novartis included Entresto, which generated $1.8 billion in sales as well as Cosentyx, which generated $1.3 billion.
Voyager Therapeutics (NASDAQ:VYGR) Trading 1 4% Higher theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) and Repligen (NASDAQ:RGEN – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership. Insider & Institutional Ownership 92.6% of Neurocrine Biosciences shares […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) fell 1.1% during trading on Tuesday . The stock traded as low as $8.07 and last traded at $8.15. 97,338 shares traded hands during mid-day trading, a decline of 90% from the average session volume of 934,279 shares. The stock had previously closed at $8.24. Analyst Ratings […]